Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
7.880 USD  -0.170 (-2.11%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Keryx Biopharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
NASDAQ Gain Momentum on Earnings (GRPN, DECK, KERX, CLDX, EGHT)
March 01, 2013
New York, NY -- (SBWIRE) -- 03/01/2013 -- TooNiceStocks.com - Sign up for weekly Technical and Equity Research Reports covering all equity sectors. We have a proven track record, please come visit and... Read More
from SBWire - Latest Press Releases
Markets Flat As Personal Income Falls
March 01, 2013
The markets traded flat during the midday with the Dow adding 4 points to 14,059 as January personal income dropped 3.6%. Nasdaq eased a fraction to 3159. Read More
category Market News
from MarketMinute.com Market Updates
Keryx Biopharmaceuticals Crosses Above its 10-day MA (KERX)
March 01, 2013
from Comtex SmarTrend® News Briefs
Trading Activity Alert for Keryx Biopharmaceuticals
March 01, 2013
NEW YORK (AVAFIN) -- Unusual volume of Keryx Biopharmaceuticals put contracts exchanged hands in ... Read More
from AVAFIN
Stocks Review (Keryx Biopharmaceuticals, SBA Communications Corporation, Prologis Inc, Manitowoc Company)
February 28, 2013
Las Vegas, NV -- (SBWIRE) -- 02/28/2013 -- Cogonews.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news... Read More
from SBWire - Latest Press Releases
Phosphate Binder Medications Target Heart and Kidney Health
February 28, 2013
New medical research is investigating the effect of phosphate binder medications on kidney and cardiovascular disease. Read More
category Financial , Stocks
from Resource Investing News
Phosphate Binder Medications Target Heart and Kidney Health
February 28, 2013
New medical research is investigating the effect of phosphate binder medications on kidney and cardiovascular disease. Read More
category Financial , Stocks
from Resource Investing News
SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Keryx Biopharmaceuticals, Inc., and Certain Officers -- KERX
February 26, 2013
from GlobeNewswire News Releases
Trading Radar for 02/27: J.C. Penney (JCP), Joy Global (JOY), Target (TGT), InterOil (IOC), Universal Display (PANL) Report
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8134166 for the full story. Read More
from StreetInsider.com News Articles
Today's Technical View on Sanofi and Keryx: Pharma Companies Yield Strong Returns
February 26, 2013
from PR Newswire
Stocks to Watch: Halcon Resources Corp, Millennial Media, Inc., Liberty Interactive (Interactive Group), Keryx Biopharmaceuticals
February 25, 2013
Lakeway, TX -- (SBWIRE) -- 02/25/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following... Read More
from SBWire - Latest Press Releases
Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
February 22, 2013
Presentation Scheduled for Wednesday, February 27th at 2:15 PM ET Read More
from PR Newswire
Activity Alert for Keryx Biopharmaceuticals
February 21, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 21 block trades on shares of Keryx ... Read More
from AVAFIN
Notable Stocks: MGIC Investment Corp, EarthLink, KB Home, Keryx Biopharmaceuticals
February 19, 2013
Lakeway, TX -- (SBWIRE) -- 02/19/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
KERX, KORS, GTE and BCRX - Pre-Market Briefing
February 14, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the WSA Financial Ltd. Read More
from Marketwired News Releases
High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
February 14, 2013
from PR Newswire
Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving magicJack VocalTec LTD., Tellabs, Inc. and Keryx Biopharmaceuticals
February 13, 2013
from Marketwired News Releases
4 Healthcare Stock Stories for Investor Well-Being (ZIOP, KERX, STEM, CLSN)
February 12, 2013
Los Angelas, CA -- (SBWIRE) -- 02/12/2013 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
NASDAQ Gain Investor Support (KERX, GEVO, SPWR, ZIOP, CIMT)
February 12, 2013
New York, NY -- (SBWIRE) -- 02/12/2013 -- Keryx Biopharmaceuticals (NASDAQ:KERX) Keryx BioPharmaceuticals surged this morning, trading at an intraday of $7.23 (+9.21%) with over 6.2 million shares that... Read More
from SBWire - Latest Press Releases
Positive Earnings Lift Markets
February 12, 2013
The markets traded higher during the midday with the Dow gaining 37 points to 14,009 on positive earnings reports. Nasdaq eased a point to 3190. Read More
category Market News
from MarketMinute.com Market Updates
Keryx (KERX) Sees Early Move Higher
February 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8084229 for the full story. Read More
from StreetInsider.com News Articles
Intra-Day Update on Selected Stocks: (NYSE:EWJ), (NASDAQ:KERX)
February 11, 2013
New York, NY -- (SBWIRE) -- 02/11/2013 -- iShares MSCI Japan Index (NYSE: EWJ) opened at $10.12 and oscillated in the range of $10.09 and $10.16 in the latest trading session. It is currently at... Read More
from SBWire - Latest Press Releases
Intra-Day Update on Selected Stocks: (NYSE:EWJ), (NASDAQ:KERX)
February 11, 2013
from SBWire Direct - Latest Press Releases
4 BioPharma Catalyst Trades Offering Good Upside Potential
February 11, 2013
category Pharmaceuticals
from Trefis
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
February 08, 2013
from PR Newswire
Harwood Feffer LLP Announces Investigation of Keryx Biopharmaceuticals, Inc.
February 08, 2013
from PR Newswire
Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
February 08, 2013
from PR Newswire
Levi & Korsinsky Notifies Investors With Losses on Their Investment in Keryx Biopharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 2, 2013 to Seek a Lead Plaintiff Position
February 07, 2013
from Marketwired News Releases
Small Cap Stocks Mostly Lower (KERX, RAD, PSE, AKS, KBH)
February 06, 2013
Las Vegas, NV -- (SBWIRE) -- 02/06/2013 -- PennyStockParlay.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Keryx Biopharmaceuticals Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
February 06, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here